As the world waits in anticipation for a COVID-19 vaccine, US biotech firm Moderna on Monday announced its experimental vaccine against is 94.5% effective against the Coronavirus.
Moderna released early results from a clinical trial with more than 30,000 participants, after US pharmaceutical company Pfizer and its German partner BioNTech last week said their vaccine was 90% effective.